# Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma

> **NCT02550613** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** The imaging biomarkers determined by MR-PET

## Key facts

- **NCT ID:** NCT02550613
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550613, "Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02550613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*